Healthcare provider profile · identity verified

Seetha Chandra

Internal Medicine · BRADDOCK, PA · NPI 1407828361

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	598	149
Amlodipine Besylate	Amlodipine Besylate	586	140
Simvastatin	Simvastatin	293	76
Losartan Potassium	Losartan Potassium	291	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	247	27
Pantoprazole Sodium	Pantoprazole Sodium	244	61
Omeprazole	Omeprazole	237	49
Lisinopril	Lisinopril	209	57
Levothyroxine Sodium	Levothyroxine Sodium	205	45
Metformin Hcl	Metformin Hcl	202	49
Albuterol Sulfate Hfa	Albuterol Sulfate	201	45
Gabapentin	Gabapentin	185	35
Clonazepam	Clonazepam	169	24
Metoprolol Tartrate	Metoprolol Tartrate	139	37
Sertraline Hcl	Sertraline Hcl	135	32
Eliquis	Apixaban	127	23
Furosemide	Furosemide	123	32
Metoprolol Succinate	Metoprolol Succinate	118	30
Tamsulosin Hcl	Tamsulosin Hcl	103	19
Alprazolam	Alprazolam	95	14
Atenolol	Atenolol	93	23
Carvedilol	Carvedilol	83	16
Potassium Chloride	Potassium Chloride	80	27
Tramadol Hcl	Tramadol Hcl	79	15
Ibuprofen	Ibuprofen	77	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	76	17
Hydrochlorothiazide	Hydrochlorothiazide	75	23
Oxycodone Hcl	Oxycodone Hcl	74	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	73	15
Trazodone Hcl	Trazodone Hcl	71	16
Hydralazine Hcl	Hydralazine Hcl	64	13
Celecoxib	Celecoxib	59	21
Citalopram Hbr	Citalopram Hydrobromide	59	12
Fluoxetine Hcl	Fluoxetine Hcl	57	suppressed
Clopidogrel	Clopidogrel Bisulfate	52	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	49	15
Rosuvastatin Calcium	Rosuvastatin Calcium	48	12
Amoxicillin	Amoxicillin	46	34
Tolterodine Tartrate Er	Tolterodine Tartrate	46	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	45	11
Jardiance	Empagliflozin	45	suppressed
Metformin Hcl Er	Metformin Hcl	45	12
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	11
Famotidine	Famotidine	41	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Xarelto	Rivaroxaban	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Glipizide	Glipizide	37	11
Spironolactone	Spironolactone	37	suppressed
Valsartan	Valsartan	37	suppressed
Entresto	Sacubitril/Valsartan	36	suppressed
Meloxicam	Meloxicam	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Azithromycin	Azithromycin	32	25
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Allopurinol	Allopurinol	27	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	14
Ventolin Hfa	Albuterol Sulfate	27	14
Mesalamine	Mesalamine	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Torsemide	Torsemide	25	suppressed
Diazepam	Diazepam	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	18
Digoxin	Digoxin	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Jantoven	Warfarin Sodium	21	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Prednisone	Prednisone	19	suppressed
Topiramate	Topiramate	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Cephalexin	Cephalexin	18	15
Levetiracetam	Levetiracetam	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Colchicine	Colchicine	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Ozempic	Semaglutide	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ibu	Ibuprofen	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Pen Needles	Pen Needle, Diabetic	13	suppressed
Primidone	Primidone	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Olanzapine	Olanzapine	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error